Larimar Therapeutics, Inc. (LRMR)
3.94
+0.12
(+3.14%)
USD |
NASDAQ |
Sep 01, 16:00
3.945
0.00 (0.00%)
Pre-Market: 20:00
Larimar Therapeutics Market Cap : 411.27M for Sept. 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 01, 2026 | 411.27M |
| August 31, 2026 | 398.74M |
| August 28, 2026 | 418.58M |
| August 27, 2026 | 422.75M |
| August 26, 2026 | 435.28M |
| August 25, 2026 | 434.23M |
| August 24, 2026 | 422.75M |
| August 21, 2026 | 436.32M |
| August 20, 2026 | 434.23M |
| August 19, 2026 | 443.63M |
| August 18, 2026 | 423.79M |
| August 17, 2026 | 450.93M |
| August 14, 2026 | 455.11M |
| August 13, 2026 | 445.72M |
| August 12, 2026 | 456.15M |
| August 11, 2026 | 449.89M |
| August 10, 2026 | 418.58M |
| August 07, 2026 | 434.23M |
| August 06, 2026 | 438.41M |
| August 05, 2026 | 427.97M |
| August 04, 2026 | 429.01M |
| August 03, 2026 | 415.44M |
| July 31, 2026 | 398.74M |
| July 30, 2026 | 399.26M |
| July 29, 2026 | 378.91M |
| Date | Value |
|---|---|
| July 28, 2026 | 399.79M |
| July 27, 2026 | 399.79M |
| July 24, 2026 | 417.53M |
| July 23, 2026 | 418.58M |
| July 22, 2026 | 419.62M |
| July 21, 2026 | 410.22M |
| July 20, 2026 | 399.79M |
| July 17, 2026 | 386.22M |
| July 16, 2026 | 383.09M |
| July 15, 2026 | 397.70M |
| July 14, 2026 | 388.30M |
| July 13, 2026 | 388.83M |
| July 10, 2026 | 446.76M |
| July 09, 2026 | 431.10M |
| July 08, 2026 | 376.82M |
| July 07, 2026 | 355.95M |
| July 06, 2026 | 343.42M |
| July 02, 2026 | 340.29M |
| July 01, 2026 | 335.07M |
| June 30, 2026 | 318.37M |
| June 29, 2026 | 334.03M |
| June 26, 2026 | 382.04M |
| June 25, 2026 | 365.34M |
| June 24, 2026 | 378.91M |
| June 23, 2026 | 384.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.669B |
| Marker Therapeutics, Inc. | 21.68M |
| Rezolute, Inc. | 433.32M |
| Krystal Biotech, Inc. | 10.77B |
| ACADIA Pharmaceuticals, Inc. | 4.973B |
Market Cap Related Metrics
| PEG Ratio | -0.0736 |
| Price to Book Value | 3.229 |
| Price | 3.94 |
| Earnings Yield | -50.33% |
| PEGY Ratio | -0.0736 |